SARS-CoV-2 infection can block pain, opening up unexpected new possibilities for research into pain relief medication
The SARS-CoV-2 virus usually infects the body via the ACE2 protein. But there is another entry point that allows the virus to infect the nervous system and block pain perception.
Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study - eClinicalMedicine
Natural products as a source of novel drugs for treating SARS-CoV2 infection - ScienceDirect
Are You a Novid—Someone Who's Never Had COVID? Science Has Some Clues Why, BU Today
Two Years into the COVID-19 Pandemic: Lessons Learned
Quantum tunnelling in the context of SARS-CoV-2 infection
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants - ScienceDirect
Frontiers Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
COVID-19 vaccine development: milestones, lessons and prospects
COVID-19 and Hearing Loss, Ear, Nose and Throat Services, University Hospitals, Cleveland, OH
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
View of Post-COVID pain syndrome Anaesthesia, Pain & Intensive Care
IJERPH, Free Full-Text
Drug Discovery Strategies for SARS-CoV-2 Journal of Pharmacology and Experimental Therapeutics
SARS-CoV-2 infection can block pain, opening up unexpected new possibilities for research into pain relief medication
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
